Cargando…

Advancing the diagnosis and classification of renal cell carcinomas

Detalles Bibliográficos
Autor principal:	Rothwell, Joseph A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524364/ https://www.ncbi.nlm.nih.gov/pubmed/34482827 http://dx.doi.org/10.1186/s12916-021-02105-2

Ejemplares similares

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Racial Disparities and Molecular Insights in Translocation Renal Cell Carcinoma: Advancing Understanding and Treatment Approaches
por: Campbell, Patrick, et al.
Publicado: (2023)

Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2023)

Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma
por: Zhang, Yue, et al.
Publicado: (2019)

Management of metastatic renal cell carcinoma: The complexity of choice
por: Brown, Jacqueline T., et al.
Publicado: (2019)

Renal cell carcinoma and plasma cell myeloma: Coincidence or true association?
por: Mubarak, Muhammed
Publicado: (2014)

Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
por: Pichler, Renate, et al.
Publicado: (2019)

A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma
por: Ivanyi, Philipp, et al.
Publicado: (2023)

Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features
por: Sircar, Kanishka, et al.
Publicado: (2013)

Prognostic models in papillary renal cell carcinoma
por: Attalla, Kyrollis, et al.
Publicado: (2020)

Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma
por: Meza, Luis, et al.
Publicado: (2022)

Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites
por: Bezwada, Divya, et al.
Publicado: (2023)

A novel classification for local recurrence after surgical removal of renal cell cancer
por: Yuasa, Takeshi
Publicado: (2020)

Combining VEGF receptor inhibitors and angiotensin-(1–7) to target renal cell carcinoma
por: Walther, Thomas, et al.
Publicado: (2021)

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
por: Gao, Xin, et al.
Publicado: (2019)

Taking a SPOP at renal cell carcinoma – unraveling a novel pathway for Tumor progression in clear cell RCC
por: Patel, Hiren V., et al.
Publicado: (2020)

Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences
por: Santoni, Matteo, et al.
Publicado: (2023)

Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma
por: White-Al Habeeb, Nicole M.A.
Publicado: (2017)

SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas
por: Dufies, Maeva
Publicado: (2020)

Recent advances on diagnosis and management of childhood asthma and food allergies
por: Hakimeh, Dani, et al.
Publicado: (2013)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

VENUSS rising for papillary renal cell carcinoma prognostication?
por: Buchler, Tomas
Publicado: (2020)

Minimalistic immunohistochemical approach to non-small cell carcinoma of the lung in small biopsies in the context of the 2015 WHO Classification of Lung Cancer
por: Siddaraju, Neelaiah
Publicado: (2017)

Clinical relevance of systematic human papillomavirus (HPV) diagnosis in oral squamous cell carcinoma
por: Bertolus, Chloé, et al.
Publicado: (2012)

Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler‐Weber‐Rendu Syndrome
por: Hahn, Andrew W., et al.
Publicado: (2018)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
por: Ivanyi, Philipp, et al.
Publicado: (2023)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach
por: Arber, Daniel A., et al.
Publicado: (2022)

Small-Cell Carcinoma of the Prostate – Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece
por: Abbott, Trish, et al.
Publicado: (2023)

Trends in percutaneous renal biopsy: The evolving diagnostic pathway for the small renal mass
por: Perera, Marlon, et al.
Publicado: (2018)

Commentary on Pancreatic Carcinoma: The Role of Radiofrequency Ablation in Advanced Disease
por: Spiliotis, John
Publicado: (2010)

Renal proximal tubule cells: power and finesse
por: Fuchs, Michaela A.A., et al.
Publicado: (2023)

Classification of Presbyopia by Severity
por: McDonald, Marguerite B., et al.
Publicado: (2021)

The definition and classification of pneumonia
por: Mackenzie, Grant
Publicado: (2016)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

Immune classification of clear cell renal cell carcinoma
por: Su, Sumeyye, et al.
Publicado: (2021)

Bridging the Gap Between Sorafinib Efficacy and Effectiveness in Advanced Hepatocellular Carcinoma
por: Nipp, Ryan, et al.
Publicado: (2016)

Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
por: Agrawal, Anand
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sfa4852o0k278hbb008p4ujnpi